# FDA Inspection 1160749 - Amarex Clinical Research, LLC - December 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/amarex-clinical-research-llc/80edfba9-eeed-43c3-b32e-9f45d770248f
Source feed: FDA_Inspections

> FDA Inspection 1160749 for Amarex Clinical Research, LLC on December 29, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160749
- Company Name: Amarex Clinical Research, LLC
- Inspection Date: 2021-12-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1158863 - 2021-11-03](https://www.keypedia.com/records/fda_inspections/amarex-clinical-research-llc/33c8fc47-645d-4a7a-b617-2f49452530e9)
- [FDA Inspection 1035083 - 2017-12-05](https://www.keypedia.com/records/fda_inspections/amarex-clinical-research-llc/ad7509b9-ef40-4217-9f61-0deedccbb547)
- [FDA Inspection 911612 - 2015-01-28](https://www.keypedia.com/records/fda_inspections/amarex-clinical-research-llc/5c99960d-3af6-4b87-acde-eafde197741b)
- [FDA Inspection 637968 - 2010-01-11](https://www.keypedia.com/records/fda_inspections/amarex-clinical-research-llc/f681dc3d-1ef5-49b4-af94-7ef16e03d272)

Company: https://www.keypedia.com/companies/amarex-clinical-research-llc/1fe4c07b-4ea1-4b76-821c-c20a7e0bfad4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c